Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000087

Drug Information
SynonymsAphrosol; NCGC00025018-05; Johimbin; Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester; SPBio_002647; Yocon; methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate; (16alpha,17alpha)-17-Hydroxy-yohimban-16-carboxylic acid methyl ester; CID8969; Baron-X; Prestwick0_000584; KBio3_001032; Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)- (9CI); C09256; Bio1_000455; APHRODINE; KBio2_000576; BPBio1_000472; KBio3_001031; KBio2_005712; NCGC00025018-06; AC1L1S1D; 4-25-00-01237 (Beilstein Handbook Reference); Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI); CHEBI:10093; Yohimbine; SMR000058527; Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.; HMS1990N17; IDI1_002213; Dayto himbin; HMS2089G19; (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester; 146-48-5; DB01392; Yohimbine (DCF); CHEMBL15245; Prestwick1_000584; nchembio705-2; I14-13374; SMR000470778; Bio1_000944; 65-19-0; BRD-K35586044-001-02-6; InChI=1/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12?,15?,17?,18-,19+/m0/s; (+)-Yohimbin; Actibine; BRN 0097276; MLS001333983; (+)-Yohimbine; EINECS 205-672-0; 17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester; STOCK1N-51304; LS-162738; Yoman; Bio2_000458; HMS1792N17; 2-Hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester; NSC19509; MolPort-001-794-653; Yohimbic acid methyl ester; Thybine; KBioSS_000576; BRD-K35586044-003-03-0; nchembio.188-comp13; Yovital; KBio2_003144; Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester; BCBcMAP01_000032; Bio1_001433; Yohimar; Quebrachine; Aphrodyne; Prestwick3_000584; HMS1362N17; SMP1_000320; methyl 17alpha-hydroxyyohimban-16alpha-carboxylate; Prestwick2_000584; KBioGR_000576; 17-Hydroxyyohimban-16-carboxylic acid methyl ester; Corynine; Yohimbol-16alpha-carboxylic acid, methyl ester (6CI); UNII-2Y49VWD90Q; BSPBio_000428; 17-Hydroxy-yohimbane-16-carboxylic acid methyl ester; Lopac0_001210; Bio2_000938; NCGC00025018-07; Yohimex; trans-Quinolizidine yohimbine; Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)-; D08685; Quebrachin; MLS000728591; BSPBio_001236; Yohimbin    
CompanyPalisades Pharmaceuticals Inc    
IndicationMale impotenceApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassMydriatics    
CAS NumberCAS 146-48-5
PubChem Compound IDCID 8969.    
PubChem Substance IDSID 11447.    
SuperDrug ATC IDG04BE04;    
SuperDrug CAS ID000146485;    
TargetAlpha-2 adrenergic receptorAntagonist[2][3][1]
Ref 1Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem. 2007;7(2):187-94. To Reference
Ref 2Acute neurotoxicity after yohimbine ingestion by a body builder. Clin Toxicol (Phila). 2009 Jul 30. [Epub ahead of print] To Reference
Ref 3Alpha2-adrenergic receptors attenuate secretagogue-induced endocytosis and promote exocytosis of intestinal NHE2 and NHE3. J Pharmacol Exp Ther. 2009 Jun 25. [Epub ahead of print] To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543